2025-11-08

#reports #HUN

[Huntsman Corporation](https://eninvs.com/all.php?name=HUN) (Chemical products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193758)
(2025-11-06, After Market Close):

- Revenue -5.2% YoY (vs -7.4% in previous quarter and historical rate -12.1%)
- EBITDA -94.6% YoY (vs -210.1% in previous quarter and historical rate -23.8%)
- EBITDA margin 0.4% decreased compared to 7.3% same period last year
- Net Debt decreased by $58 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$0.5 bln (negative), 27.6% of market cap
- EV/EBITDA multiple is 347x compared to historical level (75th percentile) of 21.1x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +4.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #GNRC

[Generac](https://eninvs.com/all.php?name=GNRC) (Power generation equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193749)
(2025-10-29, Before Market Open):

- Revenue -5.1% YoY (vs +6.3% in previous quarter and historical rate -1.1%)
- EBITDA -32.4% YoY (vs +10.7% in previous quarter and historical rate +5.7%)
- EBITDA margin 11.4% decreased compared to 16.0% same period last year
- Net Debt decreased by $68 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 18x compared to historical level (75th percentile) of 21.7x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went down -10.9% vs S&P500 +0.3%

------------------------------------------------

2025-11-08

#reports #GLP

[Global Partners LP](https://eninvs.com/all.php?name=GLP) (Oil and Gas Midstream) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193747)
(2025-11-07, Before Market Open):

- Revenue +6.2% YoY (vs +4.9% in previous quarter and historical rate -2.8%)
- EBITDA -47.8% YoY (vs +84.6% in previous quarter and historical rate +13.4%)
- EBITDA margin 2.1% decreased compared to 4.2% same period last year
- Net Debt increased by $49 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -6.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #AXL

[American Axle & Manufacturing](https://eninvs.com/all.php?name=AXL) (Auto Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193695)
(2025-11-07, Before Market Open):

- Revenue 0% YoY (vs -5.9% in previous quarter and historical rate +1.4%)
- EBITDA +3.8% YoY (vs -18.0% in previous quarter and historical rate +14.1%)
- EBITDA margin 11.0% increased compared to 10.6% same period last year
- Net Debt decreased by $136 mln over the past reporting period (18.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 14.7% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 4.9x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -2.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #AHT

[Ashford Hospitality Trust](https://eninvs.com/all.php?name=AHT) (REIT — Hotel and Motel) reported for 2025 q3
(2025-02-27, After Market Close):

- Revenue -4% YoY (vs -4.4% in previous quarter and historical rate 0.0%)
- EBITDA -19% YoY (vs -50.9% in previous quarter and historical rate +10.7%)
- EBITDA margin 17.7% decreased compared to 20.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (66.7% of market cap)
- FCF (LTM) -$0 bln (negative), 80.1% of market cap
- EV/Sales multiple is -0.1x

At the opening of the session the share price went down -2.4% vs S&P500 -0.3%

------------------------------------------------

2025-11-08

#reports #CPT
@ REITs

[Camden Property Trust](https://eninvs.com/all.php?name=CPT) (Real estate investment fund) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193661)
(2025-11-06, After Market Close):

- Revenue +2.3% YoY (vs +2.6% in previous quarter and historical rate +5.5%)
- EBITDA +90.3% YoY (vs +22.9% in previous quarter and historical rate -0.3%)
- EBITDA margin 69.2% increased compared to 37.2% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 7.1x

At the opening of the session the share price went up +0.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #WTTR

[Select Energy Services](https://eninvs.com/all.php?name=WTTR) (Complete water supply solution provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193491)
(2025-11-04, After Market Close):

- Revenue -13.2% YoY (vs -0.3% in previous quarter and historical rate +16.6%)
- EBITDA -32.8% YoY (vs -1.7% in previous quarter and historical rate +29.9%)
- EBITDA margin 13.4% decreased compared to 17.3% same period last year
- Net Debt increased by $59 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 20.1% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 5.3x
- EV/Sales multiple is 1x

At the opening of the session the share price went down -2.7% vs S&P500 -0.1%

------------------------------------------------

2025-11-08

#reports #WEYS

[Weyco Group](https://eninvs.com/all.php?name=WEYS) (Footwear and Accessories) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193488)
(2025-03-11, After Market Close):

- Revenue -1.4% YoY (vs -9.4% in previous quarter and historical rate -7.3%)
- EBITDA -27.3% YoY (vs -42.9% in previous quarter and historical rate -5.1%)
- EBITDA margin 11.0% decreased compared to 14.9% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 6.5x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went neutrally vs S&P500 +0.9%

------------------------------------------------

2025-11-08

#reports #WEN

[Wendys](https://eninvs.com/all.php?name=WEN) (Restaurants) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193487)
(2025-11-07, Before Market Open):

- Revenue -3% YoY (vs -1.8% in previous quarter and historical rate +25.9%)
- EBITDA -1% YoY (vs +8.7% in previous quarter and historical rate -7.7%)
- EBITDA margin 17.6% increased compared to 17.3% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.6% of market cap
- EV/EBITDA multiple is 14.4x compared to historical level (75th percentile) of 18x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went up +11.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #TRVG

[Trivago](https://eninvs.com/all.php?name=TRVG) (Internet Content and Information) reported for 2025 q3
(2024-02-06, Before Market Open):

- Revenue +13.7% YoY (vs +16.8% in previous quarter and historical rate +1.9%)
- EBITDA margin 7.8% increased compared to -13.0% same period last year
- Net Debt decreased by $19 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -1.2%

------------------------------------------------

2025-11-08

#reports #TRUE

[TrueCar](https://eninvs.com/all.php?name=TRUE) (Internet Content and Information) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193482)
(2025-11-05, After Market Close):

- Revenue -8.5% YoY (vs +11.9% in previous quarter and historical rate +2.7%)
- EBITDA margin -11.6% decreased compared to -6.4% same period last year
- Net Debt decreased by $11 mln over the past reporting period (5.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 54.6% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +0.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #STAA

[STAAR Surgical Co](https://eninvs.com/all.php?name=STAA) (Implantable contact lenses manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193478)
(2025-10-20, Before Market Open):

- Revenue +6.7% YoY (vs -55.6% in previous quarter and historical rate -0.9%)
- EBITDA +185.7% YoY (vs -315.4% in previous quarter)
- EBITDA margin 21.1% increased compared to 7.9% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/Sales multiple is 5.1x

At the opening of the session the share price went down -0.1% vs S&P500 +0.4%

------------------------------------------------

2025-11-08

#reports #SOI

[Solaris Oilfield Infrastructure](https://eninvs.com/all.php?name=SOI) (Oil and Gas Equipment and Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193474)
(2024-08-08, After Market Close):

- Revenue +122.7% YoY (vs +101.4% in previous quarter and historical rate +34.6%)
- EBITDA +275% YoY (vs +157.1% in previous quarter and historical rate +68.8%)
- EBITDA margin 35.9% increased compared to 21.3% same period last year
- Net Debt decreased by $79 mln over the past reporting period (18.5% of market cap)
- FCF (LTM) -$0.2 bln (negative), 38.8% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 8.5x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +2.3%

------------------------------------------------

2025-11-08

#reports #SMSI

[Smith Micro Software](https://eninvs.com/all.php?name=SMSI) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193473)
(2024-08-01, After Market Close):

- Revenue -20% YoY (vs -20.0% in previous quarter and historical rate -28.6%)
- EBITDA margin -75.0% increased compared to -100.0% same period last year
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -18.5%

------------------------------------------------

2025-11-08

#reports #SHO

[Sunstone Hotel Investors](https://eninvs.com/all.php?name=SHO) (REIT — Hotel and Motel) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193471)
(2025-11-07, Before Market Open):

- Revenue +1.3% YoY (vs +3.2% in previous quarter and historical rate +5.3%)
- EBITDA -4.2% YoY (vs -5.8% in previous quarter and historical rate +14.9%)
- EBITDA margin 20.1% decreased compared to 21.2% same period last year
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 3.1x

At the opening of the session the share price went up +1.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #SENS

[Senseonics](https://eninvs.com/all.php?name=SENS) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193470)
(2025-11-05, After Market Close):

- Revenue +100% YoY (vs +40.0% in previous quarter and historical rate +31.7%)
- EBITDA margin -237.5% increased compared to -575.0% same period last year
- Net Debt increased by $16 mln over the past reporting period (8.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 48.6% of market cap
- EV/Sales multiple is 3.8x

At the opening of the session the share price went down -1.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #SEAS

[SeaWorld Entertainment](https://eninvs.com/all.php?name=SEAS) (Theme park owner) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193468)
(2023-11-08, Before Market Open):

- Revenue -6.2% YoY (vs -1.6% in previous quarter and historical rate -0.2%)
- EBITDA -19.3% YoY (vs -10.7% in previous quarter and historical rate +8.6%)
- EBITDA margin 38.3% decreased compared to 44.5% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.2% of market cap
- EV/EBITDA multiple is 8.9x compared to historical level (75th percentile) of 8.5x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +1.7%

------------------------------------------------

2025-11-08

#reports #RUSHB

[Rush Enterprises](https://eninvs.com/all.php?name=RUSHB) (Auto and Truck Dealerships) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193466)
(2025-10-29, After Market Close):

- Revenue -0.8% YoY (vs -4.7% in previous quarter and historical rate +6.6%)
- EBITDA -9.9% YoY (vs +19.2% in previous quarter and historical rate +1.9%)
- EBITDA margin 8.7% decreased compared to 9.6% same period last year
- Net Debt decreased by $264 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) +$0.5 bln (positive), 11.8% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 9.1x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -1.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #RIGL

[Rigel Pharmaceuticals](https://eninvs.com/all.php?name=RIGL) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193465)
(2024-08-06):

- Revenue +25.5% YoY (vs +175.7% in previous quarter and historical rate +57.0%)
- EBITDA +93.3% YoY (vs +6000.0% in previous quarter and historical rate +107.8%)
- EBITDA margin 42.0% increased compared to 27.3% same period last year
- Net Debt decreased by $36 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 50.5x compared to historical level (75th percentile) of 258.7x
- EV/Sales multiple is 21.5x

------------------------------------------------

2025-11-08

#reports #RARE

[Ultragenyx Pharmaceutical](https://eninvs.com/all.php?name=RARE) (Medicines developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193463)
(2025-11-04, After Market Close):

- Revenue +15.1% YoY (vs +12.9% in previous quarter and historical rate +22.8%)
- EBITDA margin -101.3% decreased compared to -74.1% same period last year
- Net Debt decreased by $29 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.7 bln (negative), 30.9% of market cap
- EV/Sales multiple is 3.2x

At the opening of the session the share price went down -11.0% vs S&P500 -0.1%

------------------------------------------------

2025-11-08

#reports #QRTEB

[Qurate Retail](https://eninvs.com/all.php?name=QRTEB) (Internet Retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193461)
(2025-02-27, After Market Close):

- Revenue -5.6% YoY (vs -7.1% in previous quarter and historical rate -0.9%)
- EBITDA -34% YoY (vs -930.3% in previous quarter and historical rate -1.2%)
- EBITDA margin 7.4% decreased compared to 10.5% same period last year
- Net Debt increased by $52 mln over the past reporting period (18.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 44.0% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +425.0% vs S&P500 -0.3%

------------------------------------------------

2025-11-08

#reports #OTTR

[Otter Tail](https://eninvs.com/all.php?name=OTTR) (Energy provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193458)
(2025-11-03, After Market Close):

- Revenue -3.6% YoY (vs -2.6% in previous quarter and historical rate +12.6%)
- EBITDA +4.4% YoY (vs -8.0% in previous quarter and historical rate +15.9%)
- EBITDA margin 43.3% increased compared to 39.9% same period last year
- Net Debt decreased by $73 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 8.8x
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -1.2% vs S&P500 -0.9%

------------------------------------------------

2025-11-08

#reports #OESX

[Orion Energy Systems](https://eninvs.com/all.php?name=OESX) (Electrical Equipment and Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193457)
(2025-11-11, Before Market Open):

- Revenue +5.3% YoY (vs 0.0% in previous quarter and historical rate -0.5%)
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-11-08

#reports #OB

[Outbrain Inc.](https://eninvs.com/all.php?name=OB) (Internet Content and Information) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193455)
(2025-05-09, Before Market Open):

- Revenue +42.4% YoY (vs +60.3% in previous quarter and historical rate +6.8%)
- EBITDA margin -0.6% decreased compared to 0.4% same period last year
- Net Debt increased by $28 mln over the past reporting period (10.8% of market cap)
- FCF (LTM) -$0.7 bln (negative), 253.4% of market cap
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -9.9% vs S&P500 +0.3%

------------------------------------------------

2025-11-08

#reports #NR

[Newpark Resources](https://eninvs.com/all.php?name=NR) (Oil and Gas Equipment and Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193451)
(2024-11-07, After Market Close):

- Revenue +56.8% YoY (vs -62.0% in previous quarter and historical rate -19.2%)
- EBITDA +87.5% YoY (vs -14.3% in previous quarter and historical rate +56.5%)
- EBITDA margin 21.7% increased compared to 18.2% same period last year
- Net Debt decreased by $9 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 13.4x
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -6.1% vs S&P500 -0.1%

------------------------------------------------

2025-11-08

#reports #NKTR

[Nektar Therapeutics](https://eninvs.com/all.php?name=NKTR) (Medicines developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193450)
(2025-08-07, After Market Close):

- Revenue -50% YoY (vs -52.2% in previous quarter and historical rate -12.1%)
- EBITDA margin -258.3% decreased compared to -137.5% same period last year
- Net Debt decreased by $98 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/Sales multiple is 187.5x

At the opening of the session the share price went up +3.9% vs S&P500 +0.2%

------------------------------------------------

2025-11-08

#reports #MRC

[MRC Global](https://eninvs.com/all.php?name=MRC) (Pipelines and components manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193448)
(2025-11-05, Before Market Open):

- Revenue -14.9% YoY (vs -4.1% in previous quarter and historical rate -3.7%)
- EBITDA -85.4% YoY (vs -43.9% in previous quarter and historical rate +3.3%)
- EBITDA margin 1.0% decreased compared to 6.0% same period last year
- Net Debt increased by $42 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 8.3% of market cap
- EV/EBITDA multiple is 19.5x compared to historical level (75th percentile) of 9.9x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -10.0% vs S&P500 -0.1%

------------------------------------------------

2025-11-08

#reports #MNST

[Monster Beverage](https://eninvs.com/all.php?name=MNST) (Energy drink supplier) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193587)
(2025-11-06, After Market Close):

- Revenue +16.8% YoY (vs +11.1% in previous quarter and historical rate +8.7%)
- EBITDA +37.2% YoY (vs +24.3% in previous quarter and historical rate +12.6%)
- EBITDA margin 32.1% increased compared to 27.3% same period last year
- Net Debt decreased by $507 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$1.7 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 27.8x compared to historical level (75th percentile) of 27.9x
- EV/Sales multiple is 8.2x

At the opening of the session the share price went up +6.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #MMI

[Marcus & Millichap](https://eninvs.com/all.php?name=MMI) (Investment brokerage company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193447)
(2025-11-07, Before Market Open):

- Revenue +14.8% YoY (vs +8.9% in previous quarter and historical rate -14.9%)
- Net Debt decreased by $35 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 4.3% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +3.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #KFS

[Kingsway Financial Services](https://eninvs.com/all.php?name=KFS) (Auto and Truck Dealerships) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193441)
(2024-11-06, After Market Close):

- Revenue +37% YoY (vs +19.2% in previous quarter and historical rate +9.8%)
- EBITDA margin 5.4% increased compared to 3.7% same period last year
- EV/EBITDA multiple is 41.4x compared to historical level (75th percentile) of 147.8x
- EV/Sales multiple is 2.6x

------------------------------------------------

2025-11-08

#reports #JBT

[John Bean Technologies Corporation](https://eninvs.com/all.php?name=JBT) (Equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193440)
(2024-10-22, After Market Close):

- Revenue +120.5% YoY (vs +132.6% in previous quarter and historical rate +26.1%)
- EBITDA +129% YoY (vs +291.8% in previous quarter and historical rate +34.8%)
- EBITDA margin 15.8% increased compared to 15.2% same period last year
- Net Debt decreased by $18 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$1.7 bln (negative), 42.1% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 18.6x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went up +5.0% vs S&P500 -0.3%

------------------------------------------------

2025-11-08

#reports #INSG

[Inseego](https://eninvs.com/all.php?name=INSG) (Communication equipment developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193434)
(2024-05-08, After Market Close):

- Revenue -14.8% YoY (vs -32.2% in previous quarter and historical rate -16.3%)
- EBITDA +25% YoY (vs -80.0% in previous quarter)
- EBITDA margin 10.9% increased compared to 7.4% same period last year
- EV/EBITDA multiple is 188.7x compared to historical level (75th percentile) of 191.4x
- EV/Sales multiple is 11.2x

At the opening of the session the share price went up +0.3%

------------------------------------------------

2025-11-08

#reports #FLGT

[Fulgent Genetics](https://eninvs.com/all.php?name=FLGT) (Platform for automatic data analysis) reported for 2025 q3
(2025-11-07, Before Market Open):

- Revenue +16.7% YoY (vs +15.5% in previous quarter and historical rate -14.5%)
- EBITDA margin -10.7% increased compared to -15.3% same period last year
- Net Debt decreased by $491 mln over the past reporting period (60.4% of market cap)
- FCF (LTM) +$0.6 bln (positive), 70.4% of market cap
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +7.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #FET

[Forum Energy Technologies](https://eninvs.com/all.php?name=FET) (Oil and Gas Equipment and Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193425)
(2025-10-30, After Market Close):

- Revenue -5.8% YoY (vs -2.4% in previous quarter and historical rate +7.0%)
- EBITDA -125% YoY (vs -22.7% in previous quarter and historical rate -11.1%)
- EBITDA margin -1.5% decreased compared to 5.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 18.4% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -3.0% vs S&P500 +0.8%

------------------------------------------------

2025-11-08

#reports #EVER

[EverQuote](https://eninvs.com/all.php?name=EVER) (Platform for communication with auto insurers) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193546)
(2025-11-03, After Market Close):

- Revenue +20% YoY (vs +34.2% in previous quarter and historical rate +32.3%)
- EBITDA +38.5% YoY (vs +87.5% in previous quarter)
- EBITDA margin 10.3% increased compared to 9.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 29.3x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +6.3% vs S&P500 -0.9%

------------------------------------------------

2025-11-08

#reports #EEFT

[Euronet Worldwide](https://eninvs.com/all.php?name=EEFT) (Financial services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193541)
(2025-10-23, Before Market Open):

- Revenue +4.3% YoY (vs +8.9% in previous quarter and historical rate +8.2%)
- EBITDA +7% YoY (vs +14.3% in previous quarter and historical rate +16.3%)
- EBITDA margin 20.1% increased compared to 19.6% same period last year
- Net Debt increased by $27 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0.3 bln (negative), 11.3% of market cap
- EV/EBITDA multiple is 6.4x compared to historical level (75th percentile) of 9.7x
- EV/Sales multiple is 1x

At the opening of the session the share price went down -1.9% vs S&P500 +0.1%

------------------------------------------------

2025-11-08

#reports #ECOR

[electroCore](https://eninvs.com/all.php?name=ECOR) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193422)
(2023-05-17, After Market Close):

- Revenue +28.6% YoY (vs +16.7% in previous quarter and historical rate +70.7%)
- EBITDA margin -33.3% decreased compared to -28.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0 bln (negative), 25.3% of market cap
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +0.1%

------------------------------------------------

2025-11-08

#reports #DIBS

[1stdibs.Com, Inc.](https://eninvs.com/all.php?name=DIBS) (Internet Retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193417)
(2025-11-07, Before Market Open):

- Revenue +4.8% YoY (vs 0.0% in previous quarter and historical rate -3.6%)
- EBITDA margin -18.2% increased compared to -33.3% same period last year
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +14.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #CR

[Crane](https://eninvs.com/all.php?name=CR) (Engineering industrial products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193409)
(2025-10-27, After Market Close):

- Revenue -22.1% YoY (vs -30.5% in previous quarter and historical rate -11.5%)
- EBITDA +4.9% YoY (vs -29.1% in previous quarter and historical rate +8.3%)
- EBITDA margin 33.9% increased compared to 25.2% same period last year
- Net Debt decreased by $77 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.3 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 25.9x compared to historical level (75th percentile) of 21.1x
- EV/Sales multiple is 7.3x

At the opening of the session the share price went up +3.1% vs S&P500 +0.3%

------------------------------------------------

2025-11-08

#reports #CERT

[Certara, Inc.](https://eninvs.com/all.php?name=CERT) (Health Information Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193400)
(2025-11-05, After Market Close):

- Revenue +10.5% YoY (vs +12.9% in previous quarter and historical rate +24.2%)
- EBITDA +475% YoY (vs +4600.0% in previous quarter)
- EBITDA margin 21.9% increased compared to 4.2% same period last year
- Net Debt decreased by $11 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.1% of market cap
- EV/EBITDA multiple is 42.4x compared to historical level (75th percentile) of 58x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went down -0.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #CDXC

[ChromaDex Corporation](https://eninvs.com/all.php?name=CDXC) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193398)
(2025-03-04, After Market Close):

- Revenue +30.8% YoY (vs +34.8% in previous quarter and historical rate +23.0%)
- EBITDA +150% YoY (vs +200.0% in previous quarter)
- EBITDA margin 14.7% increased compared to 7.7% same period last year
- EV/EBITDA multiple is 31.3x compared to historical level (75th percentile) of 200.5x
- EV/Sales multiple is 5.1x

At the opening of the session the share price went up +19.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #BIRD

[Allbirds, Inc.](https://eninvs.com/all.php?name=BIRD) (Apparel Retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193391)
(2024-11-06, After Market Close):

- Revenue -23.3% YoY (vs -23.1% in previous quarter and historical rate -19.9%)
- EBITDA margin -48.5% decreased compared to -44.2% same period last year
- Net Debt increased by $15 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 4.2% of market cap
- EV/Sales multiple is 6x

At the opening of the session the share price went down -8.7% vs S&P500 +0.2%

------------------------------------------------

2025-11-08

#reports #ASIX

[AdvanSix](https://eninvs.com/all.php?name=ASIX) (Polymer resin manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193385)
(2025-11-07, Before Market Open):

- Revenue -6% YoY (vs -9.5% in previous quarter and historical rate +9.7%)
- EBITDA -65.4% YoY (vs -30.3% in previous quarter and historical rate +4.7%)
- EBITDA margin 4.8% decreased compared to 13.1% same period last year
- Net Debt increased by $24 mln over the past reporting period (5.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 19.8% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 7.7x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -2.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #AOMR

[Angel Oak Mortgage, Inc.](https://eninvs.com/all.php?name=AOMR) (REIT — Mortgage) reported for 2025 q3
(2025-11-11, Before Market Open):

- Revenue +11.1% YoY (vs +11.1% in previous quarter and historical rate +61.5%)
- EBITDA margin -750.0% increased compared to -855.6% same period last year
- Net Debt increased by $213 mln over the past reporting period (100.3% of market cap)
- FCF (LTM) -$0 bln (negative), 19.8% of market cap
- EV/Sales multiple is 14.9x

------------------------------------------------

2025-11-08

#reports #ANIP

[ANI Pharmaceuticals](https://eninvs.com/all.php?name=ANIP) ( Specialty pharmaceutical company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193381)
(2025-11-07, Before Market Open):

- Revenue +54.1% YoY (vs +52.9% in previous quarter and historical rate +46.4%)
- EBITDA margin 25.9% increased compared to -3.4% same period last year
- Net Debt decreased by $71 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 8.2% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 24.2x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -7.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #AMEH

[Apollo Medical](https://eninvs.com/all.php?name=AMEH) (Health care services provider ) reported for 2025 q3
(2024-02-27, After Market Close):

- Revenue +99.6% YoY (vs +34.8% in previous quarter and historical rate +42.6%)
- EBITDA -2.8% YoY (vs -28.9% in previous quarter and historical rate +20.1%)
- EBITDA margin 3.7% decreased compared to 7.5% same period last year
- Net Debt increased by $531 mln over the past reporting period (27.9% of market cap)
- FCF (LTM) -$0.6 bln (negative), 30.7% of market cap
- EV/EBITDA multiple is 23.5x compared to historical level (75th percentile) of 17.7x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +8.6%

------------------------------------------------

2025-11-08

#reports #AKA

[a.k.a. Brands Holding Corp.](https://eninvs.com/all.php?name=AKA) (Internet Retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193377)
(2023-11-08, After Market Close):

- Revenue -2% YoY (vs +403.1% in previous quarter and historical rate +6.8%)
- EBITDA +133.3% YoY (vs -60.0% in previous quarter)
- EBITDA margin 4.8% increased compared to 2.0% same period last year
- Net Debt increased by $15 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0 bln (negative), 1.8% of market cap
- EV/EBITDA multiple is 124.8x compared to historical level (75th percentile) of 185.9x
- EV/Sales multiple is 3.1x

At the opening of the session the share price went down -9.9%

------------------------------------------------

2025-11-08

#reports #ACRE

[Ares Commercial Real Estate Corporation](https://eninvs.com/all.php?name=ACRE) (REIT — Mortgage) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193375)
(2025-11-07, Before Market Open):

- Revenue -17.6% YoY (vs -23.5% in previous quarter and historical rate -16.7%)
- EBITDA -42.9% YoY (vs -75.0% in previous quarter and historical rate +9.0%)
- EBITDA margin 28.6% decreased compared to 41.2% same period last year
- Net Debt increased by $30 mln over the past reporting period (10.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 41.8% of market cap
- EV/Sales multiple is 5.7x

At the opening of the session the share price went up +4.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-08

#reports #ZI
@ saas

[ZoomInfo Technologies](https://eninvs.com/all.php?name=ZI) (Software developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193492)
(2025-05-12, After Market Close):

- Revenue +4.6% YoY (vs +5.1% in previous quarter and historical rate +7.5%)
- EBITDA +91.5% YoY (vs +470.6% in previous quarter and historical rate +36.0%)
- EBITDA margin 49.4% increased compared to 27.0% same period last year
- Net Debt increased by $45 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 11.3x compared to historical level (75th percentile) of 20.8x
- EV/Sales multiple is 4.2x

At the opening of the session the share price went down -9.9% vs S&P500 +0.2%

------------------------------------------------

2025-11-08

#reports #BDSX

[Biodesix](https://eninvs.com/all.php?name=BDSX) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193387)
(2025-10-31, After Market Close):

- Revenue +22.2% YoY (vs +11.1% in previous quarter and historical rate +32.5%)
- EBITDA margin -13.6% increased compared to -27.8% same period last year
- Net Debt increased by $5 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) -$0 bln (negative), 35.3% of market cap
- EV/Sales multiple is 1.4x

At the opening of the session the share price went down -1.0% vs S&P500 +0.6%

------------------------------------------------

2025-11-07

#reports #YELP

[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +4.4% YoY (vs +3.6% in previous quarter and historical rate +8.3%)
- EBITDA +18.2% YoY (vs +34.7% in previous quarter and historical rate +56.1%)
- EBITDA margin 20.7% increased compared to 18.3% same period last year
- Net Debt decreased by $35 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 20.8x
- EV/Sales multiple is 1.2x

------------------------------------------------

2025-11-07

#reports #XRAY

[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193370)
(2025-11-06, Before Market Open):

- Revenue -4.9% YoY (vs -4.9% in previous quarter and historical rate +4.6%)
- EBITDA margin -16.4% increased compared to -45.1% same period last year
- Net Debt decreased by $26 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.7% of market cap
- EV/Sales multiple is 0.8x

At the opening of the session the share price went down -10.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #XPOF

[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -1.2% YoY (vs -1.3% in previous quarter and historical rate +13.8%)
- EBITDA margin 8.9% increased compared to -2.5% same period last year
- Net Debt decreased by $75 mln over the past reporting period (34.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 36.3% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-11-07

#reports #WSC

[WillScot](https://eninvs.com/all.php?name=WSC) (Warehouse service provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193366)
(2025-11-06, After Market Close):

- Revenue -5.7% YoY (vs -2.6% in previous quarter and historical rate +1.8%)
- EBITDA +392.7% YoY (vs +207.1% in previous quarter and historical rate +22.6%)
- EBITDA margin 35.6% increased compared to 6.8% same period last year
- Net Debt decreased by $52 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 15.1x
- EV/Sales multiple is 3.2x

------------------------------------------------

2025-11-07

#reports #WRBY

[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193365)
(2025-11-06, Before Market Open):

- Revenue +15.6% YoY (vs +13.8% in previous quarter and historical rate +13.3%)
- EBITDA +333.3% YoY (vs -600.0% in previous quarter and historical rate +83.3%)
- EBITDA margin 5.9% increased compared to 1.6% same period last year
- Net Debt increased by $10 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 67.6x compared to historical level (75th percentile) of 306x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went up +2.1% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #VTRS

[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193362)
(2025-11-06, Before Market Open):

- Revenue +0.2% YoY (vs -5.7% in previous quarter and historical rate -5.4%)
- EBITDA -20.9% YoY (vs +73.4% in previous quarter and historical rate -22.0%)
- EBITDA margin 11.5% decreased compared to 14.6% same period last year
- Net Debt decreased by $442 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0.5 bln (negative), 3.9% of market cap
- EV/EBITDA multiple is 145.4x compared to historical level (75th percentile) of 11.6x
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-11-07

#reports #VHI

[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193361)
(2025-11-06, After Market Close):

- Revenue +8% YoY (vs -1.4% in previous quarter and historical rate -3.6%)
- EBITDA -60.7% YoY (vs -55.0% in previous quarter and historical rate +37.0%)
- EBITDA margin 4.6% decreased compared to 12.6% same period last year
- Net Debt increased by $28 mln over the past reporting period (7.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 43.1% of market cap
- EV/EBITDA multiple is 4x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-11-07

#reports #VERI

[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +31.8% YoY (vs -22.6% in previous quarter and historical rate -12.9%)
- EBITDA margin -27.6% increased compared to -68.2% same period last year
- Net Debt decreased by $23 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) +$0 bln (positive), 8.5% of market cap
- EV/Sales multiple is 4.1x

------------------------------------------------

2025-11-07

#reports #VCEL

[Vericel](https://eninvs.com/all.php?name=VCEL) (Medical services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193360)
(2025-11-06, Before Market Open):

- Revenue +17.2% YoY (vs +18.9% in previous quarter and historical rate +17.5%)
- EBITDA margin 8.8% increased compared to -1.7% same period last year
- Net Debt decreased by $20 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 132.6x compared to historical level (75th percentile) of 747.3x
- EV/Sales multiple is 7.2x

At the opening of the session the share price went up +11.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #URGN

[UroGen Pharma](https://eninvs.com/all.php?name=URGN) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193358)
(2025-11-06, Before Market Open):

- Revenue +8% YoY (vs +9.1% in previous quarter and historical rate +15.3%)
- EBITDA margin -100.0% decreased compared to -68.0% same period last year
- Net Debt increased by $32 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 8.6% of market cap
- EV/Sales multiple is 11.7x

At the opening of the session the share price went down -5.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #UPLD

[Upland Software](https://eninvs.com/all.php?name=UPLD) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193357)
(2025-11-06, Before Market Open):

- Revenue -23.9% YoY (vs -23.2% in previous quarter and historical rate -9.1%)
- EBITDA +7.1% YoY (vs -72.7% in previous quarter)
- EBITDA margin 29.4% increased compared to 20.9% same period last year
- Net Debt decreased by $35 mln over the past reporting period (66.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 314.4% of market cap
- EV/EBITDA multiple is 18.3x compared to historical level (75th percentile) of 68.9x
- EV/Sales multiple is 3.4x

At the opening of the session the share price went up +1.6% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #UEIC

[Universal Electronics](https://eninvs.com/all.php?name=UEIC) ( Innovative products manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -10.8% YoY (vs +8.9% in previous quarter and historical rate -10.8%)
- EBITDA -120% YoY (vs 0.0% in previous quarter)
- EBITDA margin -1.1% decreased compared to 4.9% same period last year
- Net Debt decreased by $10 mln over the past reporting period (22.8% of market cap)
- FCF (LTM) +$0 bln (positive), 43.4% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2025-11-07

#reports #TXG

[10X Genomics](https://eninvs.com/all.php?name=TXG) (Medical services provider) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -2% YoY (vs +13.1% in previous quarter and historical rate +9.0%)
- EBITDA margin -17.4% increased compared to -23.0% same period last year
- Net Debt decreased by $34 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0 bln (positive), 3.3% of market cap
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-11-07

#reports #TTEC

[TTEC](https://eninvs.com/all.php?name=TTEC) (IT services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193354)
(2025-11-06, After Market Close):

- Revenue -1.9% YoY (vs -3.7% in previous quarter and historical rate -3.6%)
- EBITDA -7.9% YoY (vs +4100.0% in previous quarter and historical rate -12.9%)
- EBITDA margin 6.7% decreased compared to 7.2% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 87.2% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-11-07

#reports #TRIP

[TripAdvisor](https://eninvs.com/all.php?name=TRIP) (Travel services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193351)
(2025-11-06, Before Market Open):

- Revenue +3.9% YoY (vs +6.4% in previous quarter and historical rate +13.1%)
- EBITDA +3.3% YoY (vs +46.4% in previous quarter and historical rate +10.0%)
- EBITDA margin 17.0% decreased compared to 17.1% same period last year
- Net Debt decreased by $11 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.3 bln (negative), 13.7% of market cap
- EV/EBITDA multiple is 10.7x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +6.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TPR

[Tapestry](https://eninvs.com/all.php?name=TPR) (Clothes seller) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193349)
(2025-11-06, Before Market Open):

- Revenue +13.1% YoY (vs -74.2% in previous quarter and historical rate +6.6%)
- EBITDA +25.9% YoY (vs -62.3% in previous quarter and historical rate +8.4%)
- EBITDA margin 21.6% increased compared to 19.4% same period last year
- Net Debt increased by $676 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 19.5x compared to historical level (75th percentile) of 8.6x
- EV/Sales multiple is 4.8x

At the opening of the session the share price went down -13.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TNDM

[Tandem Diabetes Care](https://eninvs.com/all.php?name=TNDM) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193348)
(2025-11-06, After Market Close):

- Revenue +2% YoY (vs +8.6% in previous quarter and historical rate +9.4%)
- EBITDA margin -8.0% increased compared to -9.4% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.3% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-11-07

#reports #TMCI

[Treace Medical Concepts, Inc.](https://eninvs.com/all.php?name=TMCI) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193347)
(2025-11-06, After Market Close):

- Revenue +11.1% YoY (vs +6.8% in previous quarter and historical rate +21.1%)
- EBITDA margin -26.0% increased compared to -28.9% same period last year
- Net Debt increased by $11 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-11-07

#reports #TKNO

[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -2.8%)
- EBITDA margin -40.0% increased compared to -70.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/Sales multiple is 3.6x

------------------------------------------------

2025-11-07

#reports #THR

[Thermon Group](https://eninvs.com/all.php?name=THR) (Specialty Industrial Machinery) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193346)
(2025-11-06, Before Market Open):

- Revenue 0% YoY (vs -5.2% in previous quarter and historical rate +7.6%)
- EBITDA 0% YoY (vs -10.5% in previous quarter and historical rate +10.4%)
- EBITDA margin 18.3% has not changed compared to 18.3% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 13.1x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +8.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TH

[Target Hospitality](https://eninvs.com/all.php?name=TH) (Oil and Gas Equipment and Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193345)
(2025-11-06, Before Market Open):

- Revenue +4.2% YoY (vs -38.6% in previous quarter and historical rate -1.6%)
- EBITDA -53.1% YoY (vs -106.7% in previous quarter and historical rate -5.4%)
- EBITDA margin 15.2% decreased compared to 33.7% same period last year
- Net Debt decreased by $36 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 26.8% of market cap
- EV/EBITDA multiple is 12.6x compared to historical level (75th percentile) of 6.9x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +3.6% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TGLS

[Tecnoglass](https://eninvs.com/all.php?name=TGLS) (Building Materials) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +9.2% YoY (vs +16.4% in previous quarter and historical rate +17.5%)
- EBITDA 0% YoY (vs +20.7% in previous quarter and historical rate +33.7%)
- EBITDA margin 28.8% decreased compared to 31.5% same period last year
- Net Debt increased by $17 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 8.6x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -2.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TFX

[Teleflex](https://eninvs.com/all.php?name=TFX) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193344)
(2025-11-06, Before Market Open):

- Revenue +19.5% YoY (vs +4.1% in previous quarter and historical rate +4.6%)
- EBITDA -328.2% YoY (vs +28.1% in previous quarter and historical rate -34.5%)
- EBITDA margin -42.5% decreased compared to 22.3% same period last year
- Net Debt increased by $685 mln over the past reporting period (14.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -3.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #TCX

[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193343)
(2025-11-06, After Market Close):

- Revenue +7.6% YoY (vs +10.1% in previous quarter and historical rate +6.0%)
- EBITDA margin 2.0% increased compared to -1.1% same period last year
- Net Debt increased by $13 mln over the past reporting period (6.3% of market cap)
- FCF (LTM) -$0.3 bln (negative), 162.6% of market cap
- EV/EBITDA multiple is 249.1x compared to historical level (75th percentile) of 41.1x
- EV/Sales multiple is 1.3x

------------------------------------------------

2025-11-07

#reports #STRA

[Strategic Education](https://eninvs.com/all.php?name=STRA) (Educational service provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193338)
(2025-11-06, Before Market Open):

- Revenue +4.6% YoY (vs +2.9% in previous quarter and historical rate +5.6%)
- EBITDA +29.8% YoY (vs +9.4% in previous quarter and historical rate +24.8%)
- EBITDA margin 19.1% increased compared to 15.4% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 15.6x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +5.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #SRTS

[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -22.2% YoY (vs -22.2% in previous quarter and historical rate +12.4%)
- EBITDA -200% YoY (vs -200.0% in previous quarter)
- EBITDA margin -28.6% decreased compared to 22.2% same period last year
- Net Debt decreased by $2 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) +$0 bln (positive), 7.0% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-11-07

#reports #SKIN

[The Beauty Health Company](https://eninvs.com/all.php?name=SKIN) (Special purpose acquisition company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193335)
(2025-11-06, After Market Close):

- Revenue -10.1% YoY (vs -14.3% in previous quarter and historical rate -3.1%)
- EBITDA margin -298.6% decreased compared to -287.3% same period last year
- Net Debt decreased by $5 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0 bln (positive), 27.7% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-11-07

#reports #SGHT

[Sight Sciences, Inc.](https://eninvs.com/all.php?name=SGHT) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193332)
(2025-11-06, After Market Close):

- Revenue 0% YoY (vs -4.8% in previous quarter and historical rate +19.9%)
- EBITDA margin -40.0% increased compared to -65.0% same period last year
- Net Debt increased by $10 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 9.2% of market cap
- EV/Sales multiple is 2.4x

------------------------------------------------

2025-11-07

#reports #SG

[Sweetgreen, Inc.](https://eninvs.com/all.php?name=SG) (Restaurants) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue -6.3% YoY (vs +0.5% in previous quarter and historical rate +42.0%)
- EBITDA margin -11.2% decreased compared to 0.3% same period last year
- Net Debt increased by $56 mln over the past reporting period (8.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.1% of market cap
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-11-07

#reports #SCSC

[ScanSource](https://eninvs.com/all.php?name=SCSC) (Scanner supplier) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193331)
(2025-11-06, Before Market Open):

- Revenue -4.6% YoY (vs +9.0% in previous quarter and historical rate +7.0%)
- EBITDA +28% YoY (vs +17.2% in previous quarter and historical rate +3.4%)
- EBITDA margin 4.3% increased compared to 3.2% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -10.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #RL

[Ralph Lauren](https://eninvs.com/all.php?name=RL) (Clothing and accessories manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193325)
(2025-11-06, Before Market Open):

- Revenue +16.5% YoY (vs +13.7% in previous quarter and historical rate +5.8%)
- EBITDA +28.9% YoY (vs +25.1% in previous quarter and historical rate +19.4%)
- EBITDA margin 15.1% increased compared to 13.6% same period last year
- Net Debt increased by $263 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.0% of market cap
- EV/EBITDA multiple is 17.2x compared to historical level (75th percentile) of 15.7x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +2.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #RGNX

[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193324)
(2025-11-06, Before Market Open):

- Revenue +25% YoY (vs -4.5% in previous quarter and historical rate +2.2%)
- EBITDA margin -163.3% increased compared to -229.2% same period last year
- Net Debt increased by $48 mln over the past reporting period (8.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 13.0% of market cap
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -1.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #QNST

[QuinStreet](https://eninvs.com/all.php?name=QNST) (Marketing services provider ) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +2.5% YoY (vs +32.3% in previous quarter and historical rate +32.3%)
- EBITDA +120% YoY (vs +100.0% in previous quarter)
- EBITDA margin 3.8% increased compared to 1.8% same period last year
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 713x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-11-07

#reports #PZZA

[Papa Johns International](https://eninvs.com/all.php?name=PZZA) (Owner of restaurants) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193322)
(2025-11-06, Before Market Open):

- Revenue +0.2% YoY (vs +4.1% in previous quarter and historical rate +10.0%)
- EBITDA -72.3% YoY (vs -6.5% in previous quarter and historical rate +20.3%)
- EBITDA margin 4.5% decreased compared to 16.4% same period last year
- Net Debt decreased by $22 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -3.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PRVA

[Privia Health Group, Inc.](https://eninvs.com/all.php?name=PRVA) (Health Information Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193318)
(2025-11-06, Before Market Open):

- Revenue +32.4% YoY (vs +23.5% in previous quarter and historical rate +17.6%)
- EBITDA +150% YoY (vs -14.3% in previous quarter and historical rate +99.9%)
- EBITDA margin 3.4% increased compared to 1.8% same period last year
- Net Debt decreased by $48 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 60.7x compared to historical level (75th percentile) of 107.9x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +5.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PRTH

[Priority Technology](https://eninvs.com/all.php?name=PRTH) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193317)
(2025-11-06, Before Market Open):

- Revenue +6.2% YoY (vs +9.1% in previous quarter and historical rate +14.2%)
- EBITDA +2.8% YoY (vs +8.2% in previous quarter and historical rate +78.6%)
- EBITDA margin 76.3% decreased compared to 78.9% same period last year
- Net Debt increased by $82 mln over the past reporting period (21.4% of market cap)
- FCF (LTM) +$1.8 bln (positive), 462.1% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went down -6.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PODD

[Insulet](https://eninvs.com/all.php?name=PODD) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193315)
(2025-11-06, Before Market Open):

- Revenue +29.8% YoY (vs +32.7% in previous quarter and historical rate +26.7%)
- EBITDA +31.3% YoY (vs +106.3% in previous quarter and historical rate +74.6%)
- EBITDA margin 20.8% increased compared to 20.6% same period last year
- Net Debt decreased by $21 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 45.8x compared to historical level (75th percentile) of 91.6x
- EV/Sales multiple is 9.1x

At the opening of the session the share price went up +3.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PLTK

[Playtika Holding Corp.](https://eninvs.com/all.php?name=PLTK) (Electronic Gaming and Multimedia) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193313)
(2025-11-06, Before Market Open):

- Revenue +8.7% YoY (vs +11.0% in previous quarter and historical rate +1.3%)
- EBITDA +0.8% YoY (vs -20.4% in previous quarter and historical rate -8.7%)
- EBITDA margin 19.3% decreased compared to 20.8% same period last year
- Net Debt decreased by $34 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 37.8% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 9x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +6.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PLNT

[Planet Fitness](https://eninvs.com/all.php?name=PLNT) ( Fitness centers owner) reported for 2025 q3
(2025-11-06, Before Market Open):

- Revenue +13% YoY (vs +13.3% in previous quarter and historical rate +16.1%)
- EBITDA +19.7% YoY (vs +11.0% in previous quarter and historical rate +48.5%)
- EBITDA margin 44.2% increased compared to 41.8% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 22.8x
- EV/Sales multiple is 8.1x

At the opening of the session the share price went up +12.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PENN

[Penn National Gaming](https://eninvs.com/all.php?name=PENN) (Provider of entertainment services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193312)
(2025-11-06, Before Market Open):

- Revenue +4.8% YoY (vs +6.1% in previous quarter and historical rate +2.5%)
- EBITDA -476.1% YoY (vs +2.2% in previous quarter and historical rate -18.6%)
- EBITDA margin -38.6% decreased compared to 10.7% same period last year
- Net Debt increased by $100 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.5% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +9.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PDFS

[PDF Solutions](https://eninvs.com/all.php?name=PDFS) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193311)
(2025-11-06, After Market Close):

- Revenue +23.9% YoY (vs +23.8% in previous quarter and historical rate +15.2%)
- EBITDA +133.3% YoY (vs +200.0% in previous quarter)
- EBITDA margin 12.3% increased compared to 6.5% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.8% of market cap
- EV/EBITDA multiple is 222.8x compared to historical level (75th percentile) of 1057x
- EV/Sales multiple is 5.4x

------------------------------------------------

2025-11-07

#reports #PCRX

[Pacira BioSciences](https://eninvs.com/all.php?name=PCRX) (Medicines manufacturer) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +6.5% YoY (vs +1.7% in previous quarter and historical rate +3.2%)
- EBITDA margin 7.8% increased compared to -78.1% same period last year
- Net Debt decreased by $53 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.0% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 1.7x

------------------------------------------------

2025-11-07

#reports #PBH

[Prestige Consumer Healthcare](https://eninvs.com/all.php?name=PBH) (Medicines manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193309)
(2025-11-06, Before Market Open):

- Revenue -3.5% YoY (vs -6.4% in previous quarter and historical rate +0.1%)
- EBITDA -5.4% YoY (vs -1.2% in previous quarter and historical rate 0.0%)
- EBITDA margin 31.8% decreased compared to 32.4% same period last year
- Net Debt increased by $19 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 11x compared to historical level (75th percentile) of 459.4x
- EV/Sales multiple is 3.6x

At the opening of the session the share price went up +2.1% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #PAR

[PAR Technology Corporation](https://eninvs.com/all.php?name=PAR) (Restaurant software and hardware solutions provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193308)
(2025-11-06, After Market Close):

- Revenue +22.7% YoY (vs +43.6% in previous quarter and historical rate +10.3%)
- EBITDA margin -16.0% increased compared to -17.5% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/Sales multiple is 3.7x

------------------------------------------------

2025-11-07

#reports #ORGO

[Organogenesis](https://eninvs.com/all.php?name=ORGO) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193305)
(2025-11-06, After Market Close):

- Revenue +31.3% YoY (vs -22.3% in previous quarter and historical rate +0.8%)
- EBITDA +150% YoY (vs -1000.0% in previous quarter)
- EBITDA margin 16.6% increased compared to 8.7% same period last year
- Net Debt increased by $61 mln over the past reporting period (11.9% of market cap)
- FCF (LTM) -$0.5 bln (negative), 106.4% of market cap
- EV/EBITDA multiple is 161.5x compared to historical level (75th percentile) of 97.6x
- EV/Sales multiple is 2.4x

------------------------------------------------

2025-11-07

#reports #OPEN

[Opendoor Technologies](https://eninvs.com/all.php?name=OPEN) (Real Estate Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193304)
(2025-11-06, After Market Close):

- Revenue -33.6% YoY (vs -70.6% in previous quarter and historical rate -16.0%)
- EBITDA -128.5% YoY (vs +800.0% in previous quarter and historical rate +7.0%)
- EBITDA margin -3.8% decreased compared to 8.9% same period last year
- Net Debt decreased by $344 mln over the past reporting period (7.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 132.8x compared to historical level (75th percentile) of 33.2x
- EV/Sales multiple is 1x

------------------------------------------------

2025-11-07

#reports #OLPX

[Olaplex Holdings, Inc.](https://eninvs.com/all.php?name=OLPX) (Specialty Retail) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193303)
(2025-11-06, Before Market Open):

- Revenue -3.4% YoY (vs +1.9% in previous quarter and historical rate -15.6%)
- EBITDA -77.4% YoY (vs -94.7% in previous quarter and historical rate -57.5%)
- EBITDA margin 6.1% decreased compared to 26.1% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.0% of market cap
- EV/EBITDA multiple is 32.7x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went up +4.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #OLED

[Universal Display](https://eninvs.com/all.php?name=OLED) (OLED research company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193302)
(2025-11-06, After Market Close):

- Revenue -13.6% YoY (vs +8.2% in previous quarter and historical rate +3.2%)
- EBITDA -23.7% YoY (vs +21.5% in previous quarter and historical rate +6.0%)
- EBITDA margin 41.4% decreased compared to 46.9% same period last year
- Net Debt decreased by $78 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 21x compared to historical level (75th percentile) of 27.3x
- EV/Sales multiple is 9.1x

------------------------------------------------

2025-11-07

#reports #NXST

[Nexstar Media](https://eninvs.com/all.php?name=NXST) (Media company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193301)
(2025-11-06, Before Market Open):

- Revenue -12.3% YoY (vs -3.2% in previous quarter and historical rate +1.6%)
- EBITDA -30.5% YoY (vs -8.5% in previous quarter and historical rate +1.0%)
- EBITDA margin 30.5% decreased compared to 38.4% same period last year
- Net Debt increased by $13 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.2% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -4.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-07

#reports #NTRA

[Natera](https://eninvs.com/all.php?name=NTRA) (Medical services provider) reported for 2025 q3
(2025-11-06, After Market Close):

- Revenue +34.5% YoY (vs +32.4% in previous quarter and historical rate +40.3%)
- EBITDA margin -15.0% decreased compared to -7.0% same period last year
- Net Debt decreased by $25 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.9% of market cap
- EV/Sales multiple is 8.8x